Mcbroom & Associates, LLC / JNJ
Mcbroom & Associates, LLC’s Johnson & Johnson Position
Does Mcbroom & Associates, LLC own Johnson & Johnson (JNJ)? Yes — 33.3K shares worth $8M (+4.53% of its 13F portfolio) as of Q1 2026, down from 36.3K shares the prior filed quarter.
Position Value
$8M
Q1 2026
Shares
33.3K
% of Portfolio
+4.53%
Quarters Held
18
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 33.3K | $8M | +4.53% |
| Q4 2025 | 36.3K | $8M | +3.66% |
| Q3 2025 | 28.1K | $5M | +2.48% |
| Q2 2025 | 29.3K | $5M | +2.78% |
| Q1 2025 | 29.3K | $5M | +2.78% |
| Q4 2024 | 30.1K | $4M | +2.46% |
| Q3 2024 | 31.4K | $5M | +3.12% |
| Q2 2024 | 28.1K | $4M | +2.57% |
| Q1 2024 | 27.9K | $4M | +2.90% |
| Q4 2023 | 28.2K | $4M | +3.22% |
| Q3 2023 | 29.0K | $5M | +3.60% |
| Q2 2023 | 26.9K | $4M | +3.51% |
| Q1 2023 | 26.1K | $4M | +3.62% |
| Q4 2022 | 27.8K | $5M | +5.34% |
| Q3 2022 | 29.1K | $5M | +5.36% |
| Q2 2022 | 29.5K | $5M | +5.70% |
| Q1 2022 | 29.9K | $5M | +4.69% |
| Q4 2021 | 30.3K | $5M | +3.90% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mcbroom & Associates, LLC’s full portfolio or all institutional holders of JNJ.